Latest Investment News

AGL Energy Limited has announced a fully franked ordinary dividend of AUD 0.24 per share for the six months ending December 2025, payable in March 2026. This dividend reflects the company’s steady financial footing amid ongoing market challenges.

Killi Resources has identified a significant gold-copper-molybdenum geochemical anomaly at its Mt Rawdon West Project in Queensland, marking a key milestone with new high-priority drill targets.

ASB’s half-year results show a modest 1% rise in cash net profit, driven by growth in home, business, and rural lending alongside a 5% increase in customer deposits. The bank is investing heavily in technology, customer experience, and social housing initiatives to support New Zealand’s long-term prosperity.

Noxopharm Limited has secured a major scientific milestone with the publication of its Sofra™ platform research in Nature Immunology, highlighting a novel anti-inflammatory mechanism with broad therapeutic potential.

Argenica Therapeutics has reported a significant increase in its half-year loss to $3.82 million, driven by reduced revenue and higher research and development expenses. The company continues to invest heavily in its neuroprotective drug candidate ARG-007 amid ongoing clinical trials.

AGL Energy reported a 42% drop in statutory profit for the half-year ended December 2025, despite a modest revenue decline and growth in customer services. The company declared a higher interim dividend, underscoring confidence amid operational challenges and a strategic pivot to renewables.

James Hardie Industries reported a robust 30% jump in Q3 FY26 net sales, driven by the AZEK acquisition and growth in key regions, while operating income declined amid integration costs and market softness.

CSL Limited has released its half-year results showing a slight revenue decline amid ongoing transformation efforts, while maintaining its full-year guidance and expanding its share buyback program.

CSL Limited reported a 7% decline in underlying NPATA to US$1.9 billion for the half-year, weighed down by restructuring costs and impairments, yet maintains full-year guidance and expands its share buy-back program.

CSL Limited reported a sharp 80% drop in net profit for the half year ended December 2025, driven by significant restructuring and impairment charges, yet maintained its growth guidance and dividend payout.

SGH Ltd reported a stable half-year EBIT of $844 million alongside a robust 32% increase in operating cash flow, driven by solid performances at Boral and WesTrac. The company reaffirmed its FY26 guidance amid ongoing operational momentum and strategic initiatives.

SGH Ltd reported a resilient first half of FY26 with stable earnings, improved margins, and a significant boost in operating cash flow, underpinning a 7% rise in its interim dividend.